Search results for: 'stackable all in on decis'
- Did you mean
- stackable alt in on decis
- stackable agl in on decis
- Related search terms
- decision markets insights and strategic priorities
- decision markets insights ad strategic priorities
- decision market insights ad strategic priorities
- decis privacy as a service market
- decision market insights and strategic priorities
-
04 Nov 2019  |  North America  |  Market Research
Global Laboratory Products Purchasing Trends, 2019–2020
An End-user Perspective on Laboratory Spending Reveals Modest 2020 Budget Increases Following Healthier 2019 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2019 that centered around the state of their laboratories in 2019 and their expectations for 2020. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-o...
$1,500.00 -
03 Feb 2021  |  North America  |  Market Research
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
$4,950.00 -
04 Sep 2018  |  North America  |  Market Research
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...
$3,000.00 -
11 Feb 2019  |  North America  |  Market Research
Global Laboratory Products Purchasing Trends, 2018–2019
An End-user Perspective on Laboratory Spending Reveals Modest 2019 Budget Increases Following Healthier 2018 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2018 that centered around the state of their laboratories in 2018 and their expectations for 2019. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-o...
$1,500.00 -
30 Mar 2023  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends, 2022–2023
End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...
$4,950.00 -
22 Sep 2022  |  North America  |  Market Research
AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics
Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade
Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...
$2,450.00 -
26 Mar 2021  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends, 2020–2021
An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-ove...
$4,950.00 -
12 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00 -
11 Dec 2020  |  North America  |  Market Research
COVID-19 Pandemic Catalyzes the Transformation of the In-vitro Diagnostics Industry
Future Growth Potential is Enriched by Alternate Testing Sites in the Point-of-Care Testing Segment
This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...
$2,450.00 -
28 Feb 2022  |  North America  |  Market Research
United States Clinical Laboratory Services Growth Opportunities
Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites
The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to val...
$2,450.00